CLINICAL_TRIALS ClinicalTrials.gov record update

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Canada

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01415401
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:40.229595+00:00
Published At: 2014-07-01T00:00:00+00:00
Record Updated At: 2014-07-01
Results Posted At: 2014-07-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Glaucoma", "Ocular Hypertension", "Open-angle Glaucoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-07-01"
protocolSection.identificationModule.nctId: "NCT01415401"
protocolSection.identificationModule.officialTitle: "Assessing the Efficacy and Tolerability of AZARGA\u00ae (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN\u00ae (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Canada"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-07-01"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.